FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy

Thursday, September 13, 2018 1 min read

Key Takeaway: FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy

Full Press Release Details

FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy.